Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
0.00%
)
US TECH 100
28,398.80
(
0.39%
)
Dow Jones
49,760.56
(
0.00%
)
Brent Oil
105.28
(
-0.46%
)
Bitcoin
80,121.21
(
-0.46%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

itsabouttime

Send PM Follow Ignore
Followers 16
Posts 1364
Boards Moderated 0
Alias Born 02/06/2014

itsabouttime

Re: None

Tuesday, 06/28/2016 8:06:36 PM

Tuesday, June 28, 2016 8:06:36 PM

Post# of 347009
NCCN

Planned studies include bavituximab in combination with pembrolizumab (AZN) in hepatocellular carcinoma,and durvalumab (MERCK) in NSCLC. Good
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote